Type I Interferon Inhibition of Superantigen Stimulation: Implications for Treatment of Superantigen-Associated Disease (Q71992499)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7648433 AND SRC:MED&resulttype=core&format=json

22 October 2019

title

Type I interferon inhibition of superantigen stimulation: implications for treatment of superantigen-associated disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7648433 AND SRC:MED&resulttype=core&format=json

22 October 2019

Type I Interferon Inhibition of Superantigen Stimulation: Implications for Treatment of Superantigen-Associated Disease (English)

1 reference

https://api.crossref.org/works/10.1089/JIR.1995.15.39

14 July 2024

1 reference

J. M. Soos

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:7648433

14 July 2024

H. M. Johnson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:7648433

14 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7648433

14 July 2024

publication date

1 January 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7648433 AND SRC:MED&resulttype=core&format=json

full work available at URL

22 October 2019

http://www.liebertpub.com/doi/pdf/10.1089/jir.1995.15.39

1 reference

https://api.crossref.org/works/10.1089/JIR.1995.15.39

Journal of Interferon and Cytokine Research

14 July 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7648433 AND SRC:MED&resulttype=core&format=json

22 October 2019

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7648433 AND SRC:MED&resulttype=core&format=json

22 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7648433 AND SRC:MED&resulttype=core&format=json

22 October 2019

page(s)

39-45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7648433 AND SRC:MED&resulttype=core&format=json

Virus interference. I. The interferon

22 October 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1089/JIR.1995.15.39

Interferons and their actions

14 July 2024

2

1 reference

https://api.crossref.org/works/10.1089/JIR.1995.15.39

Purification and properties of a major, low molecular weight protein released by the trophoblast of sheep blastocysts at day 13-21.

14 July 2024

3

1 reference

https://api.crossref.org/works/10.1089/JIR.1995.15.39

Interferon-like sequence of ovine trophoblast protein secreted by embryonic trophectoderm

14 July 2024

4

1 reference

https://api.crossref.org/works/10.1089/JIR.1995.15.39

Antiviral activity of the pregnancy recognition hormone ovine trophoblast protein-1

14 July 2024

5

1 reference

https://api.crossref.org/works/10.1089/JIR.1995.15.39

The interferons. Mechanisms of action and clinical applications

14 July 2024

6

1 reference

https://api.crossref.org/works/10.1089/JIR.1995.15.39

Kinetics of IL-2 and interferon-gamma production, expression of IL-2 receptors, and cell proliferation in human mononuclear cells exposed to staphylococcal enterotoxin A

14 July 2024

8

1 reference

https://api.crossref.org/works/10.1089/JIR.1995.15.39

Potent mitogenic activity of staphylococcal enterotoxin A requires induction of interleukin 2.

14 July 2024

9

1 reference

https://api.crossref.org/works/10.1089/JIR.1995.15.39

T-cell responses to Mls and to bacterial proteins that mimic its behavior

14 July 2024

10

1 reference

https://api.crossref.org/works/10.1089/JIR.1995.15.39

The Vβ-specific superantigen staphylococcal enterotoxin B: Stimulation of mature T cells and clonal deletion in neonatal mice

14 July 2024

11

1 reference

https://api.crossref.org/works/10.1089/JIR.1995.15.39

T cell stimulation by staphylococcal enterotoxins. Clonally variable response and requirement for major histocompatibility complex class II molecules on accessory or target cells

14 July 2024

13

1 reference

https://api.crossref.org/works/10.1089/JIR.1995.15.39

Staphylococcal enterotoxins can reactivate experimental allergic encephalomyelitis

14 July 2024

14

1 reference

https://api.crossref.org/works/10.1089/JIR.1995.15.39

Interferon beta decreases T cell activation and interferon gamma production in multiple sclerosis

14 July 2024

15

1 reference

https://api.crossref.org/works/10.1089/JIR.1995.15.39

Treatment of PL/J mice with the superantigen, staphylococcal enterotoxin B, prevents development of experimental allergic encephalomyelitis

14 July 2024

16

1 reference

https://api.crossref.org/works/10.1089/JIR.1995.15.39

Protection from experimental allergic encephalomyelitis by application of a bacterial superantigen

14 July 2024

17

1 reference

https://api.crossref.org/works/10.1089/JIR.1995.15.39

Effects of staphylococcal enterotoxin B on T cell receptor Vβ utilization and clinical manifestations of experimental allergic encephalomyelitis

14 July 2024

18

1 reference

https://api.crossref.org/works/10.1089/JIR.1995.15.39

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group

14 July 2024

19

1 reference

https://api.crossref.org/works/10.1089/JIR.1995.15.39

Interferon beta augments suppressor cell function in multiple sclerosis

14 July 2024

20

1 reference

https://api.crossref.org/works/10.1089/JIR.1995.15.39

Systemic alpha-interferon therapy of multiple sclerosis

14 July 2024

21

1 reference

https://api.crossref.org/works/10.1089/JIR.1995.15.39

Systemic lymphoblastoid interferon therapy in chronic progressive multiple sclerosis. I. Clinical and MRI evaluation

14 July 2024

22

1 reference

https://api.crossref.org/works/10.1089/JIR.1995.15.39

Digoxin toxicity presenting with visual disturbance and trigeminal neuralgia

14 July 2024

23

1 reference

https://api.crossref.org/works/10.1089/JIR.1995.15.39

Potentiation of interferon activity by mixed preparations of fibroblast and immune interferon

14 July 2024

24

1 reference

https://api.crossref.org/works/10.1089/JIR.1995.15.39

Interferon potentiation occurs at a pretranscriptive stage

14 July 2024

25

1 reference

https://api.crossref.org/works/10.1089/JIR.1995.15.39

Clostridium perfringens enterotoxin is a superantigen reactive with human T cell receptors V beta 6.9 and V beta 22

14 July 2024

28

1 reference

https://api.crossref.org/works/10.1089/JIR.1995.15.39

Selective expansion of T cells expressing T-cell receptor variable regions V beta 2 and V beta 8 in Kawasaki disease

14 July 2024

30

1 reference

https://api.crossref.org/works/10.1089/JIR.1995.15.39

14 July 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7648433 AND SRC:MED&resulttype=core&format=json

22 October 2019

1 reference